CollPlant Biotechnologies (CollPlant Biotechnologies) Equity-to-Asset : 0.83 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CollPlant Biotechnologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $28.34 Mil. CollPlant Biotechnologies's Total Assets for the quarter that ended in Dec. 2023 was $34.13 Mil. Therefore, CollPlant Biotechnologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.83.

The historical rank and industry rank for CollPlant Biotechnologies's Equity-to-Asset or its related term are showing as below:

CLGN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32 Med: 0.67 Max: 0.88
Current: 0.83

During the past 12 years, the highest Equity to Asset Ratio of CollPlant Biotechnologies was 0.88. The lowest was 0.32. And the median was 0.67.

CLGN's Equity-to-Asset is ranked better than
72.4% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs CLGN: 0.83

CollPlant Biotechnologies Equity-to-Asset Historical Data

The historical data trend for CollPlant Biotechnologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Equity-to-Asset Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.38

0.41

0.88

0.86

0.83

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.86	0.84	0.87	0.86	0.83

Competitive Comparison of CollPlant Biotechnologies's Equity-to-Asset

For the Biotechnology subindustry, CollPlant Biotechnologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Equity-to-Asset falls into.

CollPlant Biotechnologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CollPlant Biotechnologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	28.34	/	34.126
	=	0.83

CollPlant Biotechnologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	28.34	/	34.126
	=	0.83

CollPlant Biotechnologies (NAS:CLGN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

CollPlant Biotechnologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.